Medical Imaging

News on medical imaging technologies and applications.

The assay is for diagnosing lupus and is the second immunofluorescence assay cleared by the FDA for the Helios platform.

The device being developed will interpret the scattered patterns of light that has passed through the body to enable cellular-level imaging and will compete with biopsies and blood tests.

The companies will work together to develop a series of cancer screening tests that employ Preora's cytology platform and its sample-preparation technologies.

BD alleges Cytek hired away former BD employees to develop flow cytometry products to compete against BD.

A meta-analysis concluded that combining a biomarker blood test with ultrasound increased the detection of early-stage liver cancer by as much as 40 percent.